Zobrazeno 1 - 10
of 773
pro vyhledávání: '"Viloxazine"'
Autor:
Childress A; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA., Cutler AJ; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA., Adler LA; Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA., Fry N; Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA., Asubonteng K; Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA., Maldonado-Cruz Z; Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA., Formella A; Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA., Rubin J; Chief Medical Officer and Senior Vice President of Research and Development, Supernus Pharmaceuticals, Inc, 9715 Key West Avenue, Rockville, MD, USA. jrubin@supernus.com.
Publikováno v:
CNS drugs [CNS Drugs] 2024 Nov; Vol. 38 (11), pp. 891-907. Date of Electronic Publication: 2024 Oct 07.
Autor:
Almalki AH; Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif, Saudi Arabia.; Addiction and Neuroscience Research Unit, Health Science Campus, Taif University, P.O. Box 11099, Taif, Saudi Arabia., Alnemari RM; Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, Taif, Saudi Arabia., Abduljabbar MH; Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif, Saudi Arabia., Abdelazim AH; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
Publikováno v:
Luminescence : the journal of biological and chemical luminescence [Luminescence] 2024 Jul; Vol. 39 (7), pp. e4812.
Autor:
Schein J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ., Cloutier M; Analysis Group, Inc., Montréal, QC, Canada., Gauthier-Loiselle M; Analysis Group, Inc., Montréal, QC, Canada., Catillon M; Analysis Group, Inc., New York, NY., Xu C; Analysis Group, Inc., Montréal, QC, Canada., Chan D; Analysis Group, Inc., Montréal, QC, Canada., Childress A; Center for Psychiatry and Behavioral Medicine, Las Vegas, NV.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Jun; Vol. 30 (6), pp. 528-540.
Autor:
Maletic V; Department of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, SC, USA., Mattingly GW; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA., Earnest J; Medical Affairs, Supernus Pharmaceuticals, Inc, Rockville, MD, USA.
Publikováno v:
Expert review of neurotherapeutics [Expert Rev Neurother] 2024 May; Vol. 24 (5), pp. 443-455. Date of Electronic Publication: 2024 Mar 19.
Autor:
Wang Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com., Liranso T; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Maldonado-Cruz Z; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Kosheleff AR; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Nasser A; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
Publikováno v:
Clinical drug investigation [Clin Drug Investig] 2024 May; Vol. 44 (5), pp. 303-317. Date of Electronic Publication: 2024 Apr 10.
Autor:
Surman CBH; Massachusetts General Hospital, Boston, USA.; Harvard Medical School, Boston, MA, USA., Walsh DM; Massachusetts General Hospital, Boston, USA., Bond JB; Massachusetts General Hospital, Boston, USA.; Harvard Medical School, Boston, MA, USA.; Mass General Brigham Integrated Care, Somerville, MA, USA.
Publikováno v:
Journal of attention disorders [J Atten Disord] 2024 Mar; Vol. 28 (5), pp. 800-809. Date of Electronic Publication: 2024 Jan 16.
Autor:
Raible H; The Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA., D'Souza MS; The Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA.; Department of Pharmaceutical and Biomedical Sciences, The Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA.
Publikováno v:
The Annals of pharmacotherapy [Ann Pharmacother] 2023 Dec; Vol. 57 (12), pp. 1436-1448. Date of Electronic Publication: 2023 Apr 05.
Autor:
Childress A; Center for Psychiatry and Behavioral Medicine, Inc, Las Vegas, NV, USA., Sottile R; Kirk Kerkorian School of Medicine at UNLV, University of Nevada Las Vegas, Las Vegas, NV, USA., Khanbijian S; Kirk Kerkorian School of Medicine at UNLV, University of Nevada Las Vegas, Las Vegas, NV, USA.
Publikováno v:
Expert review of neurotherapeutics [Expert Rev Neurother] 2023 Jul-Dec; Vol. 23 (11), pp. 945-953. Date of Electronic Publication: 2023 Oct 27.
Autor:
Jumaili WA; Texas Tech University Health Science Center at Permian Basin, Odessa.; Corresponding Author: Wisam Al Jumaili, MD, 2301 W Michigan Ave Midland, TX 79707 (waljumai@ttuhsc.edu)., Mian N; Puget Sound Psychiatric Center Bothell, Washington., Jain S; Texas Tech University Health Science Center at Permian Basin, Odessa.
Publikováno v:
The primary care companion for CNS disorders [Prim Care Companion CNS Disord] 2023 Aug 22; Vol. 25 (4). Date of Electronic Publication: 2023 Aug 22.
Autor:
Price MZ; Hackensack Meridian School of Medicine, Nutley, NJ, 07110, USA. mzp2103@columbia.edu., Price RL; Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA.
Publikováno v:
CNS drugs [CNS Drugs] 2023 Jul; Vol. 37 (7), pp. 655-660. Date of Electronic Publication: 2023 Jul 10.